| MapLight Therapeutics, Inc. |
10%+ Owner |
Voting Common Stock |
19,697,464 |
|
|
28 Oct 2025 |
Indirect |
| MapLight Therapeutics, Inc. |
10%+ Owner |
Series A-1 Preferred Stock |
0 |
|
|
28 Oct 2025 |
Indirect |
| MapLight Therapeutics, Inc. |
10%+ Owner |
Series A Preferred Stock |
0 |
|
|
28 Oct 2025 |
Indirect |
| MapLight Therapeutics, Inc. |
10%+ Owner |
Series B-1 Preferred Stock |
0 |
|
|
28 Oct 2025 |
Indirect |
| MapLight Therapeutics, Inc. |
10%+ Owner |
Series B Preferred Stock |
0 |
|
|
28 Oct 2025 |
Indirect |
| MapLight Therapeutics, Inc. |
10%+ Owner |
Series C Preferred Stock |
0 |
|
|
28 Oct 2025 |
Indirect |
| MapLight Therapeutics, Inc. |
10%+ Owner |
Series D Preferred Stock |
0 |
|
|
28 Oct 2025 |
Indirect |